Sort
21,453 grants matching “tuberculosis”
Genes And Gene Products As Immunoadjuvants
$1,650,367Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Establishing the Genetic Basis of Altered Drug Responses in Mycobacterium tuberculosis
$1,647,916Sarah M Fortune · Harvard Medical School · U19 · FY2023 · AI
Structure Biology and Targeted Drug Design for AIDS
$1,647,609University Of California San Francisco · P01 · FY2004 · GM
Structure Biology and Targeted Drug Design for AIDS
$1,647,609University Of California San Francisco · P01 · FY2005 · GM
AIDS CLINICAL TRIALS UNIT
$1,647,267University Of Pennsylvania · U01 · FY2003 · AI
Molecular Mechanisms in Membrane Bioenergetics, Transport and Signaling
$1,646,926Jose Faraldo-Gomez · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Exploring the impact of inflammaging on immune function during M. tb infection
$1,646,449Joanne Turner · Ohio State University · P01 · FY2016 · AG
The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)
$1,643,848Chad J Achenbach · Northwestern University · U54 · FY2025 · EB
ADULT AIDS CLINICAL TRIALS UNIT
$1,643,516University Of Washington · U01 · FY2003 · AI
Structure Biology and Targeted Drug Design for AIDS
$1,642,674University Of California San Francisco · P01 · FY2003 · GM
Development Of New Chemotherapeutics For Tuberculosis
$1,642,641Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Experimental Animal Models of TB: Chemotherapeutics and Imaging
$1,642,641Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$1,641,899Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Development Of A Vaccine For Leishmania Major Infection
$1,641,899Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM
$1,641,451Jay Evans · University Of Montana · N01 · FY2025 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$1,641,447Judith S. Currier · University Of California Los Angeles · UM1 · FY2017 · AI
AIDS CLINICAL TRIALS UNIT
$1,640,820University Of California Los Angeles · U01 · FY2001 · AI
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)
$1,639,776University Of Southern California · U01 · FY2003 · AI
GHESKIO HIV Clinical Trial Unit
$1,638,659Jean William Pape · Gheskio Center · U01 · FY2011 · AI
Bacteria and Host in TB Transmission
$1,637,992David Alland · Rbhs-New Jersey Medical School · R01 · FY2020 · AI
Identification of Novel Syk/Raf-1 Mediated CLR Ligands as Vaccine Adjuvants
$1,637,656Jay Evans · University Of Montana · N01 · FY2024 · AI
AIDS CLINICAL TRIALS UNIT
$1,637,646Harvard University (Medical School) · U01 · FY2004 · AI
Tuberculosis Research Unit
$1,636,348W. Henry Henry Boom · Case Western Reserve University · N01 · FY2009 · AI
Aurum Clinical Trials Unit
$1,635,530Gavin John Churchyard · Aurum Institute Npc · UM1 · FY2025 · AI
International Epidemiology Databases to EvaluateAIDS (IeDEA) Renewal 4
$1,634,801Antoine Jaquet · Adera · U01 · FY2025 · AI